CustomID® was conceived in 2002, a joint vision by Martha Adams and Richard Drew who recognized the value of mobile devices and the delivery of clinical decision support at the point of care. Together they led the creation of “CustomID®”, a digital framework for institution-specific information for the treatment of infectious diseases.
With the help of a development team – adding Allen Coleman from DHTS and Ken Kawamoto while a candidate for MD-PhD degree in biomedical engineering – CustomID® launched in 2003 within Duke University Hospital. The enhanced version was introduced in August 2015. Today CustomID® merges with the hospital-wide antimicrobial stewardship program, a mission to improve patient safety and quality of care, and to reduce drug resistance and cost.
CustomID®, in its newest version, acknowledges the following contributors:
Martha Adams, MA, MD
Deverick Anderson, MD, MPH
Richard Drew, PharmD, MS
Tanmay Gokhale, candidate for MD-PhD in biomedical engineering
Ken Kawamoto, MD, PhD
Rebekah Moehring, MD, MPH
Christina Sarubbi, PharmD
Duke Institute for Health Innovation, Program Director, Suresh Balu
Duke University Health System – William J. Fulkerson, MD, Executive VP, and Thomas Owens, MD, Chief Medical Officer
Duke Office of Licensing & Venture - Alan Herosian, Director of Corporate Alliances and Development